Plexus (NASDAQ:PLXS) Stock Rating Upgraded by Wall Street Zen

Plexus (NASDAQ:PLXS) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Sunday, Wall Street Zen reports.

A number of other research analysts also recently weighed in on the stock. Needham & Company LLC reissued a “buy” rating and set a $310.00 target price on shares of Plexus in a research report on Friday, August 14th. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. KeyCorp raised Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price objective for the company in a report on Monday, September 21st. Stifel Nicolaus raised their target price on Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a research report on Monday, June 22nd. Finally, Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price on the stock in a research note on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $276.86.

Plexus Trading Up 0.0%

NASDAQ PLXS opened at $273.18 on Friday. The stock has a market capitalization of $7.31 billion, a price-to-earnings ratio of 40.29 and a beta of 0.88. Plexus has a one year low of $132.03 and a one year high of $307.06. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72. The business’s fifty day moving average is $254.34 and its 200-day moving average is $254.53.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, beating the consensus estimate of $2.13 by $0.19. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The company had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.23 billion. During the same quarter in the prior year, the business earned $1.64 earnings per share. The firm’s revenue for the quarter was up 28.2% on a year-over-year basis. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Equities research analysts predict that Plexus will post 7.13 EPS for the current year.

Insider Activity at Plexus

In other Plexus news, Director Michael V. Schrock sold 4,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the sale, the director owned 40,329 shares of the company’s stock, valued at $11,090,475. The trade was a 9.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Todd Kelsey sold 1,500 shares of the stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $250.98, for a total value of $376,470.00. Following the sale, the chief executive officer owned 65,888 shares in the company, valued at approximately $16,536,570.24. This represents a 2.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 7,500 shares of company stock worth $1,960,520. Corporate insiders own 1.78% of the company’s stock.

Hedge Funds Weigh In On Plexus

Large investors have recently modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Plexus during the second quarter worth about $1,311,631,000. Bank of America Corp DE purchased a new stake in Plexus in the second quarter valued at approximately $60,281,000. Bank of New York Mellon Corp bought a new stake in Plexus during the second quarter valued at approximately $55,525,000. Emerald Advisers LLC bought a new stake in Plexus during the first quarter valued at approximately $33,729,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new stake in Plexus during the second quarter valued at approximately $35,755,000. 94.45% of the stock is currently owned by institutional investors.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is an electronics manufacturing services and product development company headquartered in Neenah, Wisconsin. The company helps customers design, engineer, manufacture and service complex electronic products, offering capabilities that span product development, printed circuit board assembly, systems integration, testing, supply-chain management and aftermarket support.

Plexus serves customers in markets including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.